0 CHECKOUT

India In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

  • ID: 993048
  • September 2009
  • Region: India
  • 151 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • CL Micromed Pvt. Ltd.
  • Embee Diagnostics
  • Gen-Probe Incorporated
  • OLYMPUS CORPORATION
  • MORE

India In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to India IIn vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in India

Scope

- The report provides information on the Indian in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
- Total revenues, end users
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • CL Micromed Pvt. Ltd.
  • Embee Diagnostics
  • Gen-Probe Incorporated
  • OLYMPUS CORPORATION
  • MORE

1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in This Report
3.1 In Vitro Diagnostics
3.2 Clinical Chemistry
3.3 Genetic Testing
3.4 Haematology
3.5 Histology And Cytology
3.6 Immuno Chemistry
3.7 Infectious Immunology
3.8 Microbiology Culture
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval
5.2 Central Drugs Authority of India (CDAI)
5.3 Medical Device Regulatory Authority of India (MDRAI)
5.4 Classification of medical devices
6 Pricing and Reimbursement
6.1 Pricing and Reimbursement
7 Distribution Structure
7.1 Distribution Structure
8 In Vitro Diagnostics In India
8.1 In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015
8.2 In Vitro Diagnostics, India, Company Share (2007-2008)
9 Clinical Chemistry In India
9.1 Clinical Chemistry Overall Revenue (2000-2015)
9.2 Clinical Chemistry Distribution Share (2007-2008)
9.3 Clinical Chemistry, India, Company Share (2007-2008)
10 Genetic Testing In India
10.1 Genetic Testing Overall Revenue (2000-2015)
10.2 Genetic Testing Distribution Share (2007-2008)
10.3 Genetic Testing, India, Company Share (2007-2008)
11 Haematology In India
11.1 Haematology Overall Revenue (2000-2015)
11.2 Haematology Distribution Share (2007-2008)
11.3 Haematology, India, Company Share (2007-2008)
12 Histology and Cytology In India
12.1 Histology and Cytology Overall Revenue (2000-2015)
12.2 Histology And Cytology Distribution Share (2007-2008)
12.3 Histology And Cytology, India, Company Share (2007-2008)
13 Immuno Chemistry In India
13.1 Immuno Chemistry Overall Revenue (2000-2015)
13.2 Immuno Chemistry Distribution Share (2007-2008)
13.3 Immuno Chemistry, India, Company Share (2007-2008)
14 Infectious Immunology In India
14.1 Infectious Immunology Overall Revenue (2000-2015)
14.2 Infectious Immunology Distribution Share (2007-2008)
14.3 Infectious Immunology, India, Company Share (2007-2008)
15 Microbiology Culture In India
15.1 Microbiology Culture Overall Revenue (2000-2015)
15.2 Microbiology Culture Distribution Share (2007-2008)
15.3 Microbiology Culture, India, Company Share (2007-2008)
16 Overview of Key Companies in India In Vitro Diagnostics Market
16.1 Transasia Bio-Medicals Ltd.
16.2 F. Hoffmann-La Roche Ltd.
16.3 Siemens Healthcare
16.4 Sysmex Corporation
16.5 Abbott Laboratories
16.6 Beckman Coulter, Inc.
16.7 Ortho-Clinical Diagnostics Inc.
16.8 OLYMPUS CORPORATION
16.9 Qiagen N.V.
16.10 Span Diagnostics Ltd.
16.11 Trivitron Group of Companies
16.12 bioMerieux S.A.
16.13 Bio-Rad Laboratories, Inc.
16.14 Phadia AB
16.15 DiaSorin S.p.A
16.16 Becton, Dickinson and Company
16.17 Gen-Probe Incorporated
16.18 Inverness Medical Innovations, Inc.
16.19 Tulip Group
16.20 Mindray Medical International Limited
16.21 CL Micromed Pvt. Ltd.
16.22 Embee Diagnostics
16.23 Invitro Biotech Ltd.
16.24 Bhat Bio-tech India (P)Ltd
16.25 Accurex Biomedical Pvt. Ltd.
16.26 Jindal Medical & Scientific Instruments Company (Pvt.) Ltd.
16.27 ATNT Laboratories
16.28 Professional Biotech Pvt. Ltd.
17 Financial Deals Landscape
17.1 Acquisition
17.2 Partnerships
18 Recent Developments
18.1 Strategy And Business Planning
18.2 Government and Public Interest
19 Appendix
19.1 Global Markets Direct Research Methodology
19.2 Secondary Research
19.3 Primary Research
19.4 Models
19.5 Forecasts
19.6 Expert Panel Validation
19.7 Currency Conversion
19.8 Contact Us
19.9 Disclaimer

Executive Summary

1.1 List of Tables
Table 1: Total Healthcare Expenditure, India, 2000 - 2007 26
Table 2: Number of Doctors by Specialty in India, 2000-2006 29
Table 3: Wards by Specialty in India, 2000-2006 30
Table 4: In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015 37
Table 5: In Vitro Diagnostics, India, Cross-Category Analysis, 2000-2015 38
Table 6: In Vitro Diagnostics, India, Overall Revenue ($ mn), Historic, 2000-2008 40
Table 7: In Vitro Diagnostics, India, Overall Revenue ($ mn), Forecast, 2008-2015 42
Table 8: In Vitro Diagnostics, India, Company Share by Revenue ($ mn), 2007-2008 43
Table 9: Clinical Chemistry, India, Revenue ($ mn) by Segment, Historic, 2000-2008 45
Table 10: Clinical Chemistry, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 47
Table 11: Clinical Chemistry Analyzers, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 48
Table 12: Clinical Chemistry Analyzers, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 49
Table 13: Urine Analysis, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 50
Table 14: Urine Analysis, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 51
Table 15: Clinical Chemistry, India, Distribution Share by Revenue ($mn), 2007-2008 52
Table 16: Clinical Chemistry, India, Company Share by Revenue ($ mn), 2007-2008 54
Table 17: Genetic Testing, India, Revenue ($ mn) by Segment, Historic, 2000-2008 55
Table 18: Genetic Testing, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 56
Table 19: Genetic Testing, India, Distribution Share by Revenue ($mn), 2007-2008 57
Table 20: Genetic Testing, India, Company Share by Revenue ($ mn), 2007-2008 58
Table 21: Haematology, India, Revenue ($ mn) by Segment, Historic, 2000-2008 60
Table 22: Haematology, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 62
Table 23: Haematology Reagents, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 63
Table 24: Haematology Reagents, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 64
Table 25: Immunohaematology, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 65
Table 26: Immunohaematology, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 66
Table 27: Haemostasis, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 68
Table 28: Haemostasis, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 70
Table 29: Haematology Rapid Tests, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 71
Table 30: Haematology Rapid Tests, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 72
Table 31: Haematology Cell Counters, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 73
Table 32: Haematology Cell Counters, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 74
Table 33: Haematology, India, Distribution Share by Revenue ($mn), 2007-2008 75
Table 34: Haematology, India, Company Share by Revenue ($ mn), 2007-2008 76
Table 35: Histology and Cytology, India, Revenue ($ mn) by Segment, Historic, 2000-2008 77
Table 36: Histology and Cytology, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 78
Table 37: Histology, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 79
Table 38: Histology, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 80
Table 39: Histology And Cytology, India, Distribution Share by Revenue ($mn), 2007-2008 81
Table 40: Histology And Cytology, India, Company Share by Revenue ($ mn), 2007-2008 82
Table 41: Immuno Chemistry, India, Revenue ($ mn) by Segment, Historic, 2000-2008 84
Table 42: Immuno Chemistry, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 86
Table 43: Disease Specific Immunochemistry, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 87
Table 44: Disease Specific Immunochemistry, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 88
Table 45: Drug Related Testing, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 89
Table 46: Drug Related Testing, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 90
Table 47: Endocrinology Tests, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 91
Table 48: Endocrinology Tests, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 92
Table 49: Immunochemistry Analyzers, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 93
Table 50: Immunochemistry Analyzers, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 94
Table 51: Immuno Chemistry, India, Distribution Share by Revenue ($mn), 2007-2008 95
Table 52: Immuno Chemistry, India, Company Share by Revenue ($ mn), 2007-2008 97
Table 53: Infectious Immunology, India, Revenue ($ mn) by Segment, Historic, 2000-2008 99
Table 54: Infectious Immunology, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 101
Table 55: Infectious Immunology, India, Distribution Share by Revenue ($mn), 2007-2008 102
Table 56: Infectious Immunology, India, Company Share by Revenue ($ mn), 2007-2008 104
Table 57: Microbiology Culture, India, Revenue ($ mn) by Segment, Historic, 2000-2008 106
Table 58: Microbiology Culture, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 108
Table 59: Microbiology Analyzers, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 109
Table 60: Microbiology Analyzers, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 110
Table 61: Microbiology Culture, India, Distribution Share by Revenue ($mn), 2007-2008 111
Table 62: Microbiology Culture, India, Company Share by Revenue ($ mn), 2007-2008 113
Table 63: Sysmex Corporation Pipeline Products by Equipment Type 116
Table 64: Sysmex Corporation Pipeline Products By Development Stage 116
Table 65: Sysmex Corporation Pipeline Products By Therapy Area 116
Table 66: Sysmex Corporation Pipeline Products By News Summary 117
Table 67: Abbott Laboratories Pipeline Products by Equipment Type 118
Table 68: Abbott Laboratories Pipeline Products By Development Stage 118
Table 69: Abbott Laboratories Pipeline Products By Therapy Area 118
Table 70: Beckman Coulter, Inc. Pipeline Products by Equipment Type 119
Table 71: Beckman Coulter, Inc. Pipeline Products By Development Stage 120
Table 72: Beckman Coulter, Inc. Pipeline Products By Therapy Area 121
Table 73: Beckman Coulter, Inc. Pipeline Products By News Summary 121
Table 74: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 122
Table 75: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 123
Table 76: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area 123
Table 77: Phadia AB Pipeline Products by Equipment Type 127
Table 78: Phadia AB Pipeline Products By Development Stage 127
Table 79: Phadia AB Pipeline Products By Therapy Area 128
Table 80: Phadia AB Pipeline Products By News Summary 128
Table 81: DiaSorin S.p.A Pipeline Products by Equipment Type 129
Table 82: DiaSorin S.p.A Pipeline Products By Development Stage 129
Table 83: DiaSorin S.p.A Pipeline Products By Therapy Area 129
Table 84: Gen-Probe Incorporated Pipeline Products by Equipment Type 131
Table 85: Gen-Probe Incorporated Pipeline Products By Development Stage 132
Table 86: Gen-Probe Incorporated Pipeline Products By Therapy Area 132
Table 87: Gen-Probe Incorporated Pipeline Products By Clinical Trials 132
Table 88: Gen-Probe Incorporated Pipeline Products By News Summary 133
Table 89: Inverness Medical Innovations, Inc. Pipeline Products by Equipment Type 134
Table 90: Inverness Medical Innovations, Inc. Pipeline Products By Development Stage 135
Table 91: Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area 135
Table 92: Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials 136
Table 93: Inverness Medical Innovations, Inc. Pipeline Products By News Summary 136
Table 94: PerkinElmer Acquires Surendra Genetic Labs 140
Table 95: Rosetta Genomics Enters Into Distribution Agreement With Super Religare Laboratories 141
Table 96: DxS Signs Cross-Licensing Agreement With Epigenomics 142
Table 97: Prodesse Enters Into A licensing Agreement With Abbott Laboratories 143
Table 98: USD to Local Currency, Average Exchange Rate 2008 150

Note: Product cover images may vary from those shown
3 of 4

Transasia Bio-Medicals Ltd.
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Sysmex Corporation
Abbott Laboratories
Beckman Coulter, Inc.
Ortho-Clinical Diagnostics Inc.
OLYMPUS CORPORATION
Qiagen N.V.
Span Diagnostics Ltd.
Trivitron Group of Companies
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Phadia AB
DiaSorin S.p.A
Becton, Dickinson and Company
Gen-Probe Incorporated
Inverness Medical Innovations, Inc.
Tulip Group
Mindray Medical International Limited
CL Micromed Pvt. Ltd.
Embee Diagnostics
Invitro Biotech Ltd.
Bhat Bio-tech India (P)Ltd
Accurex Biomedical Pvt. Ltd.
Jindal Medical & Scientific Instruments Company (Pvt.) Ltd.
ATNT Laboratories
Professional Biotech Pvt. Ltd.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Luminex Corporation
  • Alere Inc.
  • Thermo Fisher Scientific Inc
  • Siemens AG
  • Genzyme Corporation
  • Quidel Corporation